Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noboru Yamamoto

Showing results (51-60 of 437) with videos related to

Pageof 44
Sort By:
Cancer Science|February 11, 2012
Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factorHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Japanese Journal of Clinical Oncology|June 4, 2011
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lungHiroshi Yoshida, Ikuo Sekine, Koji Tsuta, et al.
Oncology|October 2, 2008
Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxelHarukaze Yamamoto, Ikuo Sekine, Kazuhiko Yamada, et al.
Frontiers in Oncology|May 7, 2019
Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical TrialsTakafumi Koyama, Shunsuke Kondo, Toshio Shimizu, et al.
Biomedical Chromatography : BMC|July 28, 2009
Simple and sensitive HPLC method for determination of amrubicin and amrubicinol in human plasma: application to a clinical pharmacokinetic studyReiko Ando, Yoshinori Makino, Tomohide Tamura, et al.
International Journal of Clinical Oncology|March 16, 2017
Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in JapanAkihiko Shimomura, Shunsuke Kondo, Noriko Kobayashi, et al.
Sarcoma|June 6, 2012
Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literatureKoichi Ogura, Yasuo Beppu, Hirokazu Chuman, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancerKatsutoshi Sekine, Shintaro Kanda, Yasushi Goto, et al.
Scientific Reports|January 28, 2016
A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cellsMakiko Yamashita, Shigehisa Kitano, Hiroaki Aikawa, et al.
Japanese Journal of Clinical Oncology|November 16, 2014
A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapyKengo Nagashima, Satoru Iwasa, Takako Yanai, et al.
Pageof 44

Showing results (51-60 of 437) with videos related to

Sort By:
Pageof 44
Cancer Science|February 11, 2012
Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factorHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Japanese Journal of Clinical Oncology|June 4, 2011
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lungHiroshi Yoshida, Ikuo Sekine, Koji Tsuta, et al.
Oncology|October 2, 2008
Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxelHarukaze Yamamoto, Ikuo Sekine, Kazuhiko Yamada, et al.
Frontiers in Oncology|May 7, 2019
Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical TrialsTakafumi Koyama, Shunsuke Kondo, Toshio Shimizu, et al.
Biomedical Chromatography : BMC|July 28, 2009
Simple and sensitive HPLC method for determination of amrubicin and amrubicinol in human plasma: application to a clinical pharmacokinetic studyReiko Ando, Yoshinori Makino, Tomohide Tamura, et al.
International Journal of Clinical Oncology|March 16, 2017
Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in JapanAkihiko Shimomura, Shunsuke Kondo, Noriko Kobayashi, et al.
Sarcoma|June 6, 2012
Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literatureKoichi Ogura, Yasuo Beppu, Hirokazu Chuman, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancerKatsutoshi Sekine, Shintaro Kanda, Yasushi Goto, et al.
Scientific Reports|January 28, 2016
A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cellsMakiko Yamashita, Shigehisa Kitano, Hiroaki Aikawa, et al.
Japanese Journal of Clinical Oncology|November 16, 2014
A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapyKengo Nagashima, Satoru Iwasa, Takako Yanai, et al.
Pageof 44